4556 — Kainos Laboratories Balance Sheet
0.000.00%
- ¥5bn
- ¥3bn
- ¥5bn
- 92
- 81
- 66
- 94
Annual balance sheet for Kainos Laboratories, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1,964 | 2,244 | 2,677 | 3,020 | 3,174 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,201 | 1,206 | 1,333 | 1,411 | 1,566 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,806 | 4,058 | 4,690 | 5,219 | 5,694 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,539 | 2,532 | 2,535 | 2,547 | 2,506 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 6,745 | 6,962 | 7,572 | 8,116 | 8,591 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,848 | 1,894 | 1,781 | 1,916 | 1,980 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2,363 | 2,303 | 2,371 | 2,446 | 2,325 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 4,381 | 4,660 | 5,200 | 5,670 | 6,266 |
Total Liabilities & Shareholders' Equity | 6,745 | 6,962 | 7,572 | 8,116 | 8,591 |
Total Common Shares Outstanding |